Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ID Biomedical - Elephant Hunting?? (IDBEF) -- Ignore unavailable to you. Want to Upgrade?

To: Kaiser Soza who wrote (2)	1/19/1999 2:59:00 PM
From: Steve Lokness	Read Replies (1) \| Respond to of 27

Kaiser; Well my goodness an ID thread! I think I can help a little with my understanding of the CPT test. The reason it still takes a day for the test is because a culture still must be grown of the bacteria. Once the culture is identified then you can run the CPT test to test for resistance. What I don't understand is why you couldn't develop a DNA test for the resistant bug right from the start. Not sure who might be working on this but at least one other biotech has it mentioned deep inside their SEC filing. There are also others that are working with DNA testing such as VGIN and VYSI and even DIGE. I do agree that the need is huge as is the potential for the right test. My only problem is with management at IDBEF. How do you see the recent management changes as affecting the company? Do you believe management changes were a result of the floorless-convertable offering? Good Investing! Steve